Ethambutol/isoniazid/rifampicin explained
Type: | combo |
Component1: | ethambutol |
Class1: | anti-tuberculosis medication |
Component2: | isoniazid |
Class2: | anti-tuberculosis medication |
Component3: | rifampicin |
Class3: | anti-tuberculosis medication |
Cas Number: | 402507-77-1 |
Atc Prefix: | J04 |
Atc Suffix: | AM07 |
Chemspiderid: | none |
Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a fixed-dose combination medication used to treat tuberculosis. It contains ethambutol, isoniazid, and rifampicin. It is used either along or with other anti-tuberculosis medication. It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]
It is on the World Health Organization's List of Essential Medicines.[2]
See also
Further reading
External links
- Web site: Ethambutol . U.S. National Library of Medicine . Drug Information Portal .
- Web site: Isoniazid . U.S. National Library of Medicine . Drug Information Portal .
- Web site: Rifampin . U.S. National Library of Medicine . Drug Information Portal .
Notes and References
- Book: WHO Model Formulary 2008 . 2009 . 9789241547659 . ((World Health Organization)) . Stuart MC, Kouimtzi M, Hill SR . 10665/44053 . World Health Organization . World Health Organization . 142 .
- Book: ((World Health Organization)) . World Health Organization model list of essential medicines: 21st list 2019 . 2019 . 10665/325771 . World Health Organization . World Health Organization . Geneva . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO . free .